Ascend Wellness Reports Q4 and 2021 Results: Total Revenues Increased 135% YoY
Ascend Wellness Holdings, Inc.
PURA Plans ‘To Disrupt’ $200 Billion Steel Rebar Market With Hemp Alternative
Puration, Inc. (OTC: PURA), a cannabis cultivation technology company, announced it "plans to disrupt the $200 billion steel rebar market with a hemp alternative".
Vegan Stocks Bolstered By Rising Interest In Textured Vegetable Protein Options
Initially invented and patented in the 1960s to extend ground meat as a means of reducing costs without reducing nutritional value, Textured Vegetable Proteins (TVPs) have recently received a huge boost from growing demand in plant-based protein options for vegetarians, vegans, and flexitarians,” reported FN Media Group in a
APPlife Digital Solutions Completes Initial Phase Of LollipopNFT, User-Friendly Platform For NFTs
APPlife Digital Solutions, Inc (OTCQB: ALDS), a business incubator and portfolio manager that invests in and creates e-commerce and cloud-based solutions announced on Thursday that it has completed the important first stage of its all-inclusive, user-friendly non-fungible-token (NFT) platform
Analyst On Green Thumb Industries: Impacted By Competition, Still A Top-Pick MSO
The Analyst:
Pablo Zuanic, from Cantor Fitzgerald, kept an Overweight rating for Green Thumb Industries (OTCQX: GTBIF) (GTII.CN), and a price target at $41.
The Thesis:
BioLife Sciences Inc. To Incorporate New Sub-Sector Dedicated To CBD
BioLife Sciences (OTCPK: BLFE), a firm dedicated to developing, licensing, and distributing antimicrobial products and disruptive technologies, announced on Tuesday that it is expanding its recently announced orthomolecular medicine and natural health products department to now include a subsector dedicated to non-psychoactive cannabinoids derived from industrial hemp, includin
Jazz Pharmaceuticals Announces Full Year And 4Q 2021 Financial Results
Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company and manufacturer of Epidolex, announced its financial results late Tuesday for the full year and fourth quarter of 2021 and provided financial guidance for 2022.
Cara Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
Cara Therapeutics, Inc. (NASDAQ: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the fourth quarter and full year ended December 31, 2021.
Brief Thoughts Ahead Of 4Q For Curaleaf Holdings: New Jersey Could Be Next Main Catalyst
The Analyst
Pablo Zuanic, from Cantor Fitzgerald, kept Curaleaf (CSE:CURA) (OTCQX: CURLF) among the firm’s top picks in the MSO group, with an Overweight rating and a price target at US$16.50.
The Thesis
What’s The Top Job Creator In America Right Now? The Answer Might Surprise You
Leafly (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for consumers, released its sixth annual marijuana industry jobs report.